← Leaderboards
David Yoonsuk Oh
University Of California, San Francisco
$995,490
Attributed
$995,490
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $199.1K · FY2019–23$200K$150K$100K$50K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$995,490 · 1
By mechanism
K08$995,490 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Mark S Anderson$96,401,564
- Hideho Okada$20,052,698
- Jason G. Cyster$29,153,268
- Scott S Zamvil$12,721,345
- Julie Zikherman$10,368,290
Others in their field
Other Emerging Leaders on “Clinical Biomarkers”
- Leonard Freedman · Leidos Biomedical Research, Inc.$248,951,562
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$74,281,368
- Yunda Huang · Fred Hutchinson Cancer Center$53,780,853
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
Research focus
Clinical BiomarkersClinical TrialsCancer PatientCellsAreaAntigenic SpecificityAutoantigensAffectAdvisory CommitteesAutoimmune ResponsesAutoimmunityAutoreactive T CellAwardAutoantibodiesBasic ScienceBindingAntigensBiometryBloodAnti-Tumor Immune ResponseB-LymphocytesCaliforniaCancer ImmunotherapyClinical Trials Design
Grant awards (5)
Identification of circulating and tissue-specific autoimmune responses in checkpoint inhibitor-induced immune-related adverse events$199,098
K08 · FY2023 · AI · contact PI
Identification of circulating and tissue-specific autoimmune responses in checkpoint inhibitor-induced immune-related adverse events$199,098
K08 · FY2022 · AI · contact PI
Identification of circulating and tissue-specific autoimmune responses in checkpoint inhibitor-induced immune-related adverse events$199,098
K08 · FY2021 · AI · contact PI
Identification of circulating and tissue-specific autoimmune responses in checkpoint inhibitor-induced immune-related adverse events$199,098
K08 · FY2020 · AI · contact PI
Identification of circulating and tissue-specific autoimmune responses in checkpoint inhibitor-induced immune-related adverse events$199,098
K08 · FY2019 · AI · contact PI